Adtalem Global Education (NYSE:CVSA) CFO Robert Phelan Sells 10,000 Shares

Adtalem Global Education Inc. (NYSE:CVSA) CFO Robert Phelan sold 10,000 shares of Adtalem Global Education stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $126.21, for a total transaction of $1,262,100.00. Following the completion of the sale, the chief financial officer owned 55,806 shares of the company’s stock, valued at $7,043,275.26. This represents a 15.20% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Stock Down 1.5%

Shares of CVSA stock opened at $128.28 on Wednesday. The business has a 50 day moving average of $112.44. Adtalem Global Education Inc. has a 52 week low of $86.97 and a 52 week high of $156.26. The company has a market capitalization of $4.37 billion, a price-to-earnings ratio of 19.98, a PEG ratio of 1.08 and a beta of 0.63. The company has a debt-to-equity ratio of 0.36, a current ratio of 0.70 and a quick ratio of 0.70.

Adtalem Global Education (NYSE:CVSA) last announced its quarterly earnings results on Thursday, May 7th. The company reported $1.98 EPS for the quarter, topping analysts’ consensus estimates of $1.73 by $0.25. Adtalem Global Education had a net margin of 12.26% and a return on equity of 20.19%. The firm had revenue of $487.03 million during the quarter. During the same quarter in the prior year, the firm earned $1.92 earnings per share. The business’s revenue was up 4.5% compared to the same quarter last year. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. Analysts anticipate that Adtalem Global Education Inc. will post 8.03 earnings per share for the current year.

Analysts Set New Price Targets

CVSA has been the subject of a number of research analyst reports. Truist Financial lifted their price target on shares of Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a research note on Monday. Barrington Research reiterated an “outperform” rating and issued a $170.00 price target on shares of Adtalem Global Education in a research note on Friday, April 17th. Weiss Ratings began coverage on shares of Adtalem Global Education in a report on Wednesday, February 25th. They issued a “hold (c+)” rating on the stock. Wall Street Zen downgraded shares of Adtalem Global Education from a “buy” rating to a “hold” rating in a report on Saturday. Finally, Zacks Research downgraded shares of Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a report on Wednesday, March 25th. Two analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $155.00.

Adtalem Global Education Company Profile

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.